BofA raised the firm’s price target on Alexandria Real Estate (ARE) to $61 from $60 and keeps a Neutral rating on the shares after a Q4 beat on one-time items. While the firm credits management for what it calls “their measured commentary” despite increasingly bullish headlines around biotech, it says it still lacks visibility into the return of sustained demand.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARE:
- Balanced Risk-Reward Amid Mixed Fundamentals and Uncertain Demand Supports Hold on Alexandria Real Estate Equities
- Alexandria Real Estate Maps a Difficult 2026 Trough
- Vanguard S&P 500 ETF (VOO) Daily Update, 1/28/2026
- SPY ETF Daily Update, 1/28/2026
- Vanguard S&P 500 ETF (VOO) Daily Update, 1/27/2026
